217 related articles for article (PubMed ID: 34589581)
1. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
Cui Z; Wang Q; Deng MH; Han QL
Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
4. Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis.
Gao Y; Xie M; Guo Y; Yang Q; Hu S; Li Z
Front Genet; 2020; 11():715. PubMed ID: 32849774
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer.
Ge C; Dong J; Chu Y; Cao S; Zhang J; Wei J
Aging (Albany NY); 2020 Jul; 12(14):14355-14364. PubMed ID: 32675387
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FGD5-AS1 reduces cardiomyocyte apoptosis and inflammation by modulating Akt and miR-223-3p expression.
Zhao Y; Wang C; Cui T; Wang Q; Xu Y; Miao C; Liu S
Am J Transl Res; 2022; 14(9):6175-6186. PubMed ID: 36247255
[TBL] [Abstract][Full Text] [Related]
7. lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes.
Fang XL; Shi SG
Hum Exp Toxicol; 2022; 41():9603271221138969. PubMed ID: 36445031
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
Li B; Yu X; Pang F
Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
[TBL] [Abstract][Full Text] [Related]
12. microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2.
Chen W; Chen Y; Hui T
J Chemother; 2023 Oct; 35(6):539-549. PubMed ID: 36546770
[TBL] [Abstract][Full Text] [Related]
13. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
Ding Y; Gao S; Zheng J; Chen X
Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
[TBL] [Abstract][Full Text] [Related]
14. FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis.
Yang Y; Sun Z; Liu F; Bai Y; Wu F
Cartilage; 2021 Dec; 13(2_suppl):1412S-1420S. PubMed ID: 33834880
[TBL] [Abstract][Full Text] [Related]
15. FGD5-AS1 facilitates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting the miR-506-3p/BMP7 axis.
Li J; Wu X; Shi Y; Zhao H
J Orthop Surg Res; 2021 Nov; 16(1):665. PubMed ID: 34772438
[TBL] [Abstract][Full Text] [Related]
16. LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.
Lin J; Liao S; Liu Z; Li E; Wu X; Zeng W
Cancer Biol Ther; 2021 Mar; 22(3):257-266. PubMed ID: 33794727
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
[TBL] [Abstract][Full Text] [Related]
18. Long-Noncoding RNA FGD5-AS1 Enhances the Viability, Migration, and Invasion of Glioblastoma Cells by Regulating the miR-103a-3p/TPD52 Axis.
Su D; Ji Z; Xue P; Guo S; Jia Q; Sun H
Cancer Manag Res; 2020; 12():6317-6329. PubMed ID: 32848452
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway.
Hu J; Huang L; Ding Q; Lv J; Chen Z
Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
Chen H; Lan Z; Li Q; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2098-2106. PubMed ID: 31144533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
